Literature DB >> 10202022

Persistent HIV-1-specific CTL clonal expansion despite high viral burden post in utero HIV-1 infection.

C Brander1, P J Goulder, K Luzuriaga, O O Yang, K E Hartman, N G Jones, B D Walker, S A Kalams.   

Abstract

To address the issue of clonal exhaustion in humans, we monitored HLA class I-restricted, epitope-specific CTL responses in an in utero HIV-1-infected infant from 3 mo through 5 years of age. Serial functional CTL precursor assays demonstrated persistent, vigorous, and broadly directed HIV-1 specific CTL activity with a dominant response against an epitope in HIV-1 Gag-p17 (SLYNTVATL, aa 77-85). A clonal CTL response directed against the immunodominant, HLA-A*0201-restricted epitope was found to persist over the entire observation period, as shown by TCR analysis of cDNA libraries generated from PBMC. The analysis of autologous viral sequences did not reveal any escape mutations within the targeted epitope, and viral load measurement indicated ongoing viral replication. Furthermore, inhibition of viral replication assays indicated that the epitope was properly processed from autologous viral protein. These data demonstrate that persistent exposure to high levels of viral Ag does not necessarily lead to clonal exhaustion and that epitope-specific clonal CTL responses induced within the first weeks of life can persist for years without inducing detectable viral escape variants.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202022

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection.

Authors:  M Dalod; M Dupuis; J C Deschemin; C Goujard; C Deveau; L Meyer; N Ngo; C Rouzioux; J G Guillet; J F Delfraissy; M Sinet; A Venet
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  Persistence of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte clones in a subject with rapid disease progression.

Authors:  S A Islam; C M Hay; K E Hartman; S He; A K Shea; A K Trocha; M J Dynan; N Reshamwala; S P Buchbinder; N O Basgoz; S A Kalams
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

3.  Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection.

Authors:  Thillagavathie Pillay; Hua-Tang Zhang; Jan W Drijfhout; Nicola Robinson; Helen Brown; Munira Khan; Jagadesa Moodley; Miriam Adhikari; Katja Pfafferott; Margaret E Feeney; Anne St John; Edward C Holmes; Hoosen M Coovadia; Paul Klenerman; Philip J R Goulder; Rodney E Phillips
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy.

Authors:  M Dalod; M Dupuis; J C Deschemin; D Sicard; D Salmon; J F Delfraissy; A Venet; M Sinet; J G Guillet
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

5.  Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses.

Authors:  K Luzuriaga; M McManus; M Catalina; S Mayack; M Sharkey; M Stevenson; J L Sullivan
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection.

Authors:  Todd M Allen; Peicheng Jing; Briana Calore; Helen Horton; David H O'Connor; Tomas Hanke; Marian Piekarczyk; Richard Ruddersdorf; Bianca R Mothé; Carol Emerson; Nancy Wilson; Jeffrey D Lifson; Igor M Belyakov; Jay A Berzofsky; Chenxi Wang; David B Allison; David C Montefiori; Ronald C Desrosiers; Steven Wolinsky; Kevin J Kunstman; John D Altman; Alessandro Sette; Andrew J McMichael; David I Watkins
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Clonal focusing of epitope-specific CD8+ T lymphocytes in rhesus monkeys following vaccination and simian-human immunodeficiency virus challenge.

Authors:  Pritha Sen; William A Charini; Ramu A Subbramanian; Edwin R Manuel; Marcelo J Kuroda; Patrick A Autissier; Norman L Letvin
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

8.  Selective induction of CTL helper rather than killer activity by natural epitope variants promotes dendritic cell-mediated HIV-1 dissemination.

Authors:  Robbie B Mailliard; Kellie N Smith; Ronald J Fecek; Giovanna Rappocciolo; Eduardo J M Nascimento; Ernesto T Marques; Simon C Watkins; James I Mullins; Charles R Rinaldo
Journal:  J Immunol       Date:  2013-08-02       Impact factor: 5.422

9.  CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control.

Authors:  Beatriz Mothe; Anuska Llano; Javier Ibarrondo; Jennifer Zamarreño; Mattia Schiaulini; Cristina Miranda; Marta Ruiz-Riol; Christoph T Berger; M José Herrero; Eduard Palou; Montse Plana; Morgane Rolland; Ashok Khatri; David Heckerman; Florencia Pereyra; Bruce D Walker; David Weiner; Roger Paredes; Bonaventura Clotet; Barbara K Felber; George N Pavlakis; James I Mullins; Christian Brander
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

10.  Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences.

Authors:  Christoph T Berger; Jonathan M Carlson; Chanson J Brumme; Kari L Hartman; Zabrina L Brumme; Leah M Henry; Pamela C Rosato; Alicja Piechocka-Trocha; Mark A Brockman; P Richard Harrigan; David Heckerman; Daniel E Kaufmann; Christian Brander
Journal:  J Exp Med       Date:  2010-01-11       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.